When the SWI/SNF Complex Remodels . . . the Cell Cycle
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Original Article EP300 Regulates the Expression of Human Survivin Gene in Esophageal Squamous Cell Carcinoma
Int J Clin Exp Med 2016;9(6):10452-10460 www.ijcem.com /ISSN:1940-5901/IJCEM0023383 Original Article EP300 regulates the expression of human survivin gene in esophageal squamous cell carcinoma Xiaoya Yang, Zhu Li, Yintu Ma, Xuhua Yang, Jun Gao, Surui Liu, Gengyin Wang Department of Blood Transfusion, The Bethune International Peace Hospital of China PLA, Shijiazhuang 050082, Hebei, P. R. China Received January 6, 2016; Accepted March 21, 2016; Epub June 15, 2016; Published June 30, 2016 Abstract: Survivin is selectively up-regulated in various cancers including esophageal squamous cell carcinoma (ESCC). The underlying mechanism of survivin overexpression in cancers is needed to be further studied. In this study, we investigated the effect of EP300, a well known transcriptional coactivator, on survivin gene expression in human esophageal squamous cancer cell lines. We found that overexpression of EP300 was associated with strong repression of survivin expression at the mRNA and protein levels. Knockdown of EP300 increased the survivin ex- pression as indicated by western blotting and RT-PCR analysis. Furthermore, our results indicated that transcription- al repression mediated by EP300 regulates survivin expression levels via regulating the survivin promoter activity. Chromatin immunoprecipitation (ChIP) analysis revealed that EP300 was associated with survivin gene promoter. When EP300 was added to esophageal squamous cancer cells, increased EP300 association was observed at the survivin promoter. But the acetylation level of histone H3 at survivin promoter didn’t change after RNAi-depletion of endogenous EP300 or after overexpression of EP300. These findings establish a negative regulatory role for EP300 in survivin expression. Keywords: Survivin, EP300, transcription regulation, ESCC Introduction transcription factors and the basal transcrip- tion machinery, or by providing a scaffold for Survivin belongs to the inhibitor of apoptosis integrating a variety of different proteins [6]. -
Redundancy and Specificity F Mechta-Grigoriou Et Al 2379
Oncogene (2001) 20, 2378 ± 2389 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc The mammalian Jun proteins: redundancy and speci®city Fatima Mechta-Grigoriou1, Damien Gerald1 and Moshe Yaniv*,1 1Unite des virus oncogenes, CNRS URA 1644, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris Cedex 15, France The AP-1 transcription factor is composed of a mixture transcription factors. These proteins are characterized of homo- and hetero-dimers formed between Jun and Fos by a highly charged, basic DNA binding domain, proteins. The dierent Jun and Fos family members vary immediately adjacent to an amphipathic dimerization signi®cantly in their relative abundance and their domain, referred as the `Leucine zipper' (Kouzarides interactions with additional proteins generating a and Zi, 1988; Landschulz et al., 1988). Dimerization complex network of transcriptional regulators. Thus, is required for speci®c and high anity binding to the the functional activity of AP-1 in any given cell depends palindromic DNA sequence, TGAC/GTCA (Rauscher on the relative amount of speci®c Jun/Fos proteins which et al., 1988; Gentz et al., 1989; Hirai and Yaniv, 1989; are expressed, as well as other potential interacting Ransone et al., 1989; Schuermann et al., 1989; Turner proteins. This diversity of AP-1 components has and Tjian, 1989). The dierent AP-1 dimers exhibit complicated our understanding of AP-1 function and similar DNA binding speci®cities but dier in their resulted in a paucity of information about the precise transactivation eciencies (Chiu et al., 1989; Hirai et role of individual AP-1 members in distinct cellular al., 1990; Kerppola and Curran, 1991b; Suzuki et al., processes. -
CSHL AR 1981.Pdf
ANNUAL REPORT 1981 COLD SPRING HARBOR LABORATORY Cold Spring Harbor Laboratory Box 100, Cold Spring Harbor, New York 11724 1981 Annual Report Editors: Annette Kirk, Elizabeth Ritcey Photo credits: 9, 12, Elizabeth Watson; 209, Korab, Ltd.; 238, Robert Belas; 248, Ed Tronolone. All otherphotos by Herb Parsons. Front and back covers: Sammis Hall, new residence facility at the Banbury Conference Center.Photos by K orab, Ltd. COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR, LONG ISLAND, NEW YORK OFFICERS OF THE CORPORATION Walter H. Page, Chairman Dr. Bayard Clarkson, Vice-Chairman Dr. Norton D. Zinder, Secretary Robert L. Cummings, Treasurer Roderick H. Cushman, Assistant Treasurer Dr. James D. Watson, Director William R. Udry, Administrative Director BOARD OF TRUSTEES Institutional Trustees Individual Trustees Albert Einstein College of Medicine John F. Carr Dr. Matthew Scharff Emilio G. Collado Robert L. Cummings Columbia University Roderick H. Cushman Dr. Charles Cantor Walter N. Frank, Jr. John P. Humes Duke Mary Lindsay Dr. Robert Webster Walter H. Page William S. Robertson Long Island Biological Association Mrs. Franz Schneider Edward Pulling Alexander C. Tomlinson Dr. James D. Watson Massachusetts Institute of Technology Dr. Boris Magasanik Honorary Trustees Memorial Sloan-Kettering Cancer Center Dr. Bayard Clarkson Dr. Harry Eagle Dr. H. Bentley Glass New York University Medical Center Dr. Alexander Hollaender Dr. Claudio Basilico The Rockefeller University Dr. Norton D. Zinder State University of New York, Stony Brook Dr. Thomas E. Shenk University of Wisconsin Dr. Masayasu Nomura Wawepex Society Bache Bleeker Yale University Dr. Charles F. Stevens Officers and trustees are as of December 31, 1981 DIRECTOR'S REPORT 1981 The daily lives of scientists are much less filled now be solvable or whether we must await the re- with clever new ideas than the public must im- ception of some new facts that as yet do not exist. -
Journal of Molecular Biology
JOURNAL OF MOLECULAR BIOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.6 ISSN: 0022-2836 DESCRIPTION . Journal of Molecular Biology (JMB) provides high quality, comprehensive and broad coverage in all areas of molecular biology. The journal publishes original scientific research papers that provide mechanistic and functional insights and report a significant advance to the field. The journal encourages the submission of multidisciplinary studies that use complementary experimental and computational approaches to address challenging biological questions. Research areas include but are not limited to: Biomolecular interactions, signaling networks, systems biology Cell cycle, cell growth, cell differentiation Cell death, autophagy Cell signaling and regulation Chemical biology Computational biology, in combination with experimental studies DNA replication, repair, and recombination Development, regenerative biology, mechanistic and functional studies of stem cells Epigenetics, chromatin structure and function Gene expression Receptors, channels, and transporters Membrane processes Cell surface proteins and cell adhesion Methodological advances, both experimental and theoretical, including databases Microbiology, virology, and interactions with the host or environment Microbiota mechanistic and functional studies Nuclear organization Post-translational modifications, proteomics Processing and function of biologically -
Novel Mechanisms of Transcriptional Regulation by Leukemia Fusion Proteins
Novel mechanisms of transcriptional regulation by leukemia fusion proteins A dissertation submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirement for the degree of Doctor of Philosophy in the Department of Cancer and Cell Biology of the College of Medicine by Chien-Hung Gow M.S. Columbia University, New York M.D. Our Lady of Fatima University B.S. National Yang Ming University Dissertation Committee: Jinsong Zhang, Ph.D. Robert Brackenbury, Ph.D. Sohaib Khan, Ph.D. (Chair) Peter Stambrook, Ph.D. Song-Tao Liu, Ph.D. ABSTRACT Transcription factors and chromatin structure are master regulators of homeostasis during hematopoiesis. Regulatory genes for each stage of hematopoiesis are activated or silenced in a precise, finely tuned manner. Many leukemia fusion proteins are produced by chromosomal translocations that interrupt important transcription factors and disrupt these regulatory processes. Leukemia fusion proteins E2A-Pbx1 and AML1-ETO involve normal function transcription factor E2A, resulting in two distinct types of leukemia: E2A-Pbx1 t(1;19) acute lymphoblastic leukemia (ALL) and AML1-ETO t(8;21) acute myeloid leukemia (AML). E2A, a member of the E-protein family of transcription factors, is a key regulator in hematopoiesis that recruits coactivators or corepressors in a mutually exclusive fashion to regulate its direct target genes. In t(1;19) ALL, the E2A portion of E2A-Pbx1 mediates a robust transcriptional activation; however, the transcriptional activity of wild-type E2A is silenced by high levels of corepressors, such as the AML1-ETO fusion protein in t(8;21) AML and ETO-2 in hematopoietic cells. -
A Choice Between Transcriptional Enhancement and Repression by the V-Erba Oncoprotein Governed by One Nucleotide in a Thyroid Hormone Responsive Half Site
Oncogene (2000) 19, 3563 ± 3569 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site ML Andersson1 and B VennstroÈ m*,1 1Department of Cell and Molecular Biology (CMB), Karolinska Institute, Box 285, S-171 77 Stockholm, Sweden The v-erbA oncoprotein (P75gag-v-erbA) can repress thyroid paradigm view of P75gag-v-erbA in transcription is that hormone receptor induced transcriptional activation of P75gag-v-erbA functions as a dominant transcriptional target genes. A central question is how hormone repressor on activated transcription induced by TR responsive elements in a target gene determine the (Damm et al., 1989; Disela et al., 1991; Zenke et al., transcriptional regulation mediated by P75gag-v-erbA.We 1988). addressed this with receptors chimeric between Hormone response elements for TR (TREs) have P75gag-v-erbA and thyroid hormone receptor (TR) by testing been identi®ed in upstream or intron regions of several their regulatory activities on thyroid hormone response genes that are important in development and in elements (TREs) diering in the sequence of the homeostasis (Baniahmad et al., 1990; Desai-Yajnik et consensus core recognition motif AGGTCA. We report al., 1995; Farsetti et al., 1992; Glass et al., 1987; Petty here that enhances, TR dependent transcriptional et al., 1990; Tsika et al., 1990; WahlstroÈ m et al., 1992; activation is conferred by P75gag-v-erbA when the thymidine Wong et al., 1997). These elements contain AGGTCA in the half site recognition motif is exchanged for an or AGGACA hexamers in which two or more motifs adenosine. -
Saturday, April 14, 2007
Saturday, April 14, 2007 8:00-10:00 AM Educational Sessions Systems Biology as an Integrative Approach to Cancer, Arul M. Chinnaiyan, Chairperson, Room 403 A-B, Los Angeles Convention How to Design and Interpret Large-Scale Sequence Analyses of Center, p. 65 Human Cancer, Victor E. Velculescu, Chairperson, Room 408 A-B, Los Angeles Convention Center, p. 57 Targeted Cancer Therapy: Mono-specific versus Multi-targeted Strategies, Axel Ullrich, Chairperson, Concourse E, Los Angeles Manipulating the Immune System in Cancer Immunotherapy, Convention Center, p. 65 James P. Allison, Chairperson, Petree C, Los Angeles Convention Saturday Event Schedule Center, p. 58 Targeted Delivery of siRNA and Small Molecule Inhibitors, Jackson B. Gibbs, Chairperson, Concourse F, Los Angeles Convention Modeling Chemoprevention in Mice: The Next Generation, Cory Center, p. 66 Abate-Shen, Chairperson, Room 515 B, Los Angeles Convention Center, p. 58 The Ras Pathway: From Cancer Biology to Translational Opportunities, Dafna Bar-Sagi, Chairperson, Room 304 A-C, Los Novel Approaches to Drug Delivery in Cancer, Mark E. Davis, Angeles Convention Center, p. 66 Chairperson, Room 304 A-C, Los Angeles Convention Center, p. 59 Oxidative Stress and Senescence, Amato J. Giaccia, Chairperson, Room 515 A, Los Angeles Convention Center, p. 59 10:15 AM-12:15 PM Methods Workshops The Polygenic Basis of Phenotypic Variation and Disease: Lessons from Humans and Model Organisms, Bruce A. J. Ponder, Advances in Imaging: From Molecules and Live-Cell Research to Chairperson, Petree D, Los Angeles Convention Center, p. 60 Animal Models and Clinical Applications, Jiri Bartek, Chairperson, Room 515 B, Los Angeles Convention Center, p. -
ESID Newsletter 2007 1 Contents
Contents Obituary 2 Introduction 3 ESID information 4 President’s letter 5 Secretary’s report 5 Treasurer’s report 7 News & Views 7 Journal of Experimental Medicine 7 Genetics and Mechanisms of Susceptibility to Infectious Diseases” Pasteur Institute, aris 7 21-24 November 2007 The 6th Prague Spring ESID Meeting , Prague, May 14 and 15, 2007 8 Suggestions to the ESID community for the Journal of Primary Immunodeficiency? 9 ESID Prague Spring Meeting, May 14 and 15, 2007 FORM 10 Scheduled J Project Meetings (No. 19 to 21) 2007 11 Report on the 1st J Project Meeting in Bucharest 11 J Project meeting in Zaporozhye, East-Ukraine, 19-20 April 2007 12 Laboratory of Human Genetics of Infectious Diseases, post-doc positions 12 Working Party reports 13 Educational 13 Genetics 13 Registries 14 Juniors 19 PID care in development 19 Interesting Papers 19 Interesting Cases 21 Young Researchers’ Corner 23 Roland Levinsky, 1943-2007 Roland was a pioneer and inspirational leader in the field of primary immunodeficiency. Although originally from South Africa, Roland spent his adult life in the UK, 26 years of it at the Insti- tute of Child Health (ICH) and Great Ormond Street Hospital (GOS) in London. Roland attended medical school in London (University College London) and then trained in paediatrics in Birmingham and London before moving to Great Ormond Street Hospital in London in 1973. He subsequently became Senior Lecturer and Honorary Consultant Immunologist at GOS and Hugh Greenwood Pro- fessor of Immunology in 1985, a Chair he held at the Institute of Child Health, until he left London in 2002 to be Vice-Chancellor of Plymouth University. -
Mechanisms of Prokaryotic Gene Regulation
Overview: Conducting the Genetic Orchestra • Prokaryotes and eukaryotes alter gene expression in response to their changing environment • In multicellular eukaryotes, gene expression regulates development and is responsible for differences in cell types • RNA molecules play many roles in regulating gene expression in eukaryotes Copyright © 2008 Pearson Education Inc., publishing as Pearson Benjamin Cummings Fig. 18-1 1 Concept 18.1: Bacteria often respond to environmental change by regulating transcription • Natural selection has favored bacteria that produce only the products needed by that cell • A cell can regulate the production of enzymes by feedback inhibition or by gene regulation • Gene expression in bacteria is controlled by the operon model Copyright © 2008 Pearson Education Inc., publishing as Pearson Benjamin Cummings Fig. 18-2 Precursor Feedback inhibition trpE gene Enzyme 1 trpD gene Regulation of gene expression Enzyme 2 trpC gene trpB gene Enzyme 3 trpA gene Tryptophan (a) Regulation of enzyme (b) Regulation of enzyme activity production 2 Operons: The Basic Concept • A cluster of functionally related genes can be under coordinated control by a single on-off “switch” • The regulatory “switch” is a segment of DNA called an operator usually positioned within the promoter • An operon is the entire stretch of DNA that includes the operator, the promoter, and the genes that they control Copyright © 2008 Pearson Education Inc., publishing as Pearson Benjamin Cummings • The operon can be switched off by a protein repressor • The repressor prevents gene transcription by binding to the operator and blocking RNA polymerase • The repressor is the product of a separate regulatory gene Copyright © 2008 Pearson Education Inc., publishing as Pearson Benjamin Cummings 3 • The repressor can be in an active or inactive form, depending on the presence of other molecules • A corepressor is a molecule that cooperates with a repressor protein to switch an operon off • For example, E. -
RB and Cell Cycle Progression
Oncogene (2006) 25, 5220–5227 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc REVIEW RB and cell cycle progression C Giacinti1,2 and A Giordano1,2 1Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA, USA and 2Department of Human Pathology and Oncology, University of Siena, Siena, Italy The Rb protein is a tumor suppressor, which plays a of a tumor suppressor. Several human tumors show pivotal role in the negative control of the cell cycle and in mutations and deletions of the Rb gene, and inherited tumor progression. It has been shown that Rb protein allelic loss of Rb confers increased susceptibility to (pRb)is responsible for a major G1 checkpoint, blocking cancer formation (Dunn et al., 1988). The Rb gene is S-phase entry and cell growth. The retinoblastoma family functionally inactivated in most human neoplasms includes three members, Rb/p105, p107 and Rb2/p130, either by direct mutation/deletion, such as in retino- collectively referred to as ‘pocket proteins’. The pRb blastoma, osteosarcoma and small-cell lung carcinoma, protein represses gene transcription, required for transi- or indirectly through altered expression/activity of tion from G1 to S phase, by directly binding to the upstream regulators (Liu et al., 2004). Nevertheless, transactivation domain of E2F and by binding to the the Rb protein plays a pivotal role in the negative promoter of these genes as a complex with E2F. pRb control of the cell cycle and in tumor progression. represses transcription also by remodeling chromatin It has been shown that Rb protein (pRb) is structure through interaction with proteins such as responsible for a major G1 checkpoint (restriction hBRM, BRG1, HDAC1 and SUV39H1, which are point) blocking S-phase entry and cell growth, promot- involved in nucleosome remodeling, histone acetylation/ ing terminal differentiation by inducing both cell cycle deacetylation and methylation, respectively. -
Transcription Coactivators and Corepressors
EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 32, No. 2, 53-60, June 2000 Dissecting the molecular mechanism of nuclear receptor action: transcription coactivators and corepressors Jae Woon Lee1,2,4, JaeHun Cheong1,2, nucleosomal remodeling histone acetyl transferase (HAT) Young Chul Lee1,2, Soon-Young Na1,3 or deacetylase (HDAC) activities. Thus, these proteins and Soo-Kyung Lee1,3 appear to function by either remodeling chromatin struc- tures and/or acting as adapter molecules between nu- clear receptors and the components of the basal trans- 1 Center for Ligand and Transcription criptional apparatus. Herein, we discuss the recent pro- 2 Hormone Research Center gress in studies of these coactivators and corepressors 3 Department of Biology, Chonnam National University, of nuclear receptors. Kwangju 500-757, Korea 4 Corresponding author: Tel, +82-62-530-0910; Fax, +82-62-530-0772; E-mail, [email protected] The p160 Family Accepted 21 June 2000 A group of related proteins were found to enhance Abbreviations: HRE, hormone response elements; LBD, ligand ligand-induced transactivation function of several nuclear binding domain; AF2, activation function; HAT, histone acetyl trans- receptors, named the p160 family. These proteins are ferase; HDAC, deacetylase; CBP, CREB-binding protein; TRAPs, grouped into three subclasses based on their sequence homology; i.e., SRC-1/NCoA-1 (Hong et al., 1997; Torchia thyroid homone receptor associated proteins; VDR, vitamin D3; ASC-1, activating signal cointegrator-1; RAR, retinoic acid receptor et al., 1997; Voegel et al., 1998), TIF2/GRIP1/NCoA-2 (Hong et al., 1997; Voegel et al., 1998), and p/CIP/ ACTR/AIB1/xSRC-3 (Anzick et al., 1997; Chen et al., 1997; Kim et al., 1998; Torchia et al., 1997). -
DNA-Binding Specificities of Plant Transcription Factors and Their Potential to Define Target Genes
DNA-binding specificities of plant transcription factors and their potential to define target genes José M. Franco-Zorrillaa,1, Irene López-Vidrieroa, José L. Carrascob, Marta Godoya, Pablo Verab, and Roberto Solanoc,1 aGenomics Unit and cDepartment of Plant Molecular Genetics, Centro Nacional de Biotecnología (CNB)-Consejo Superior de Investigaciones Científicas (CSIC), Darwin 3, 28049 Madrid, Spain; and bInstituto de Biología Molecular y Celular de Plantas, Universidad Politécnica de Valencia-Consejo Superior de Investigaciones Científicas, 46022 Valencia, Spain Edited by Philip N. Benfey, Duke University, Durham, NC, and approved January 2, 2014 (received for review August 29, 2013) Transcription factors (TFs) regulate gene expression through bind- The application of high-throughput in vitro techniques is ing to cis-regulatory specific sequences in the promoters of their making the identification of the binding-sequences of all of the target genes. In contrast to the genetic code, the transcriptional TFs in a genome an affordable task. SELEX-seq and protein- regulatory code is far from being deciphered and is determined binding microarrays (PBMs) have yielded information of binding by sequence specificity of TFs, combinatorial cooperation between motifs for hundreds of TFs in mammals but these studies still TFs and chromatin competence. Here we addressed one of these lack of a simple and systematic analysis of the biological rele- determinants by characterizing the target sequence specificity of vance of the motifs (3, 4). In this study, we defined the DNA- 63 plant TFs representing 25 families, using protein-binding micro- binding motifs for 63 Arabidopsis thaliana TFs in vitro by means arrays. Remarkably, almost half of these TFs recognized secondary of PBM analysis, with a particular emphasis of plant-specific motifs, which in some cases were completely unrelated to the pri- families, and observed that approximately half of them may mary element.